[1]
“The INCA trial: a multicenter, randomized, phase II, open-label clinical trial to evaluate the combination therapy with Ipilimumab plus Nivolumab versus Chemotherapy (Pemetrexate-Cisplatin) in patients with Advanced non-squamous NSCLC naive to treatment”, PPCR, vol. 4, no. 1, pp. 6–13, Jul. 2018, Accessed: Jun. 25, 2024. [Online]. Available: https://journal.ppcr.org/index.php/ppcrjournal/article/view/62